Skip to Content

Corteva Inc CTVA Stock Quote

| Rating as of

Morningstar‘s Stock Analysis CTVA

Valuation
Currency in USD
Is it the right time to buy or sell?
Is it the right time to buy or sell?

1-Star Price

INVESTOR

5-Star Price

INVESTOR

Economic Moat

INVESTOR

Capital Allocation

INVESTOR

Raising Corteva FVE to $70 on Improved Long-Term Outlook Following Investor Day

Analyst Note

| Seth Goldstein, CFA |

We raise our Corteva fair value estimate to $70 per share from $60 following the company's investor day. The key drivers behind our outlook are increased profitability in both the seed and crop protection businesses. We maintain our wide moat rating. At current prices, we view shares as slightly undervalued with the stock trading nearly 10% below our updated fair value estimate but in 3-star territory.

Unlock Our Full Analysis With Morningstar Investor

Key Statistics CTVA

Company Profile CTVA

Business Description

Corteva is an agriculture pure play that was formed in 2019 when it was spun off from DowDuPont. The company is a leader in the development of new seed and crop chemicals products. Seeds generate a little over half of total company profits and crop protection chemicals make up the remainder. Although Corteva operates globally, around half of revenue comes from North America.

Contact
974 Centre Road
Wilmington, DE, 19805
T +1 302 774-1000
Industry Agricultural Inputs
Most Recent Earnings Jun 30, 2022
Fiscal Year End Dec 31, 2022
Employees 21,000

Related News CTVA